Health economics of kidney replacement therapy in Singapore: Taking stock and looking ahead.
- Author:
Behram Ali KHAN
1
;
Tripti SINGH
;
Anne Lay Choo NG
;
Rachel Zui Chih TEO
Author Information
1. Department of Medical Services, The National Kidney Foundation Singapore, Singapore.
- Publication Type:Journal Article
- MeSH:
Female;
Humans;
Incidence;
Kidney Failure, Chronic/therapy*;
Male;
Prevalence;
Renal Replacement Therapy/adverse effects*;
Singapore/epidemiology*
- From:Annals of the Academy of Medicine, Singapore
2022;51(4):236-240
- CountrySingapore
- Language:English
-
Abstract:
The prevalence of end-stage kidney disease (ESKD) in Singapore remains high and continues to rise. We continue to face major challenges in containing the rising incidence of ESKD and providing sustainable kidney replacement therapy. Our cost projections provide an insight into the present and future, urging a call to action to augment existing initiatives to address the emergent issues.
